Apathy is the most common neuropsychiatric symptom in patients with Alzheimer's disease (AD). The presence of apathy has been related to greater caregiver distress, decreased quality of life, and increased morbidity. Here we review the most recent studies on this neuropsychiatric syndrome, focusing on prevalence, impact on quality of life, behavioural and neuroimaging studies, and treatment options. The results of some investigations on the behavioural and neuroanatomical profile of apathy in AD point to a role of frontostriatal circuits, specifically involving the anterior cingulate cortex. However, small and heterogeneous samples, lack of control for disease severity, and non-specific apathy scales complicate interpretation of results. Future studies might benefit from studying multiple dimensions of apathy within conceptual frameworks which allow for a deconstruction of underlying mechanisms.
Introduction
The most common neuropsychiatric symptom in patients with Alzheimer's disease (AD) is apathy [1 ,2] , defined as loss of or diminished motivation in at least two out of three domains -goal-directed behaviour, cognitive activity or emotion -sufficient to cause significant impairment in everyday life [3] . Recent work in both healthy people and AD confirms the emerging view that apathy is not a single construct but a multidimensional disorder (Figure 1 ), that can also include distinct social as well as emotional deficits [4, 5] .
The presence of apathy has been related to greater caregiver distress [6] [7] [8] , decreased quality of life [9 ] , and increased morbidity [10] . Although distinguishable from each other, apathy often co-occurs with depression.
While some symptoms of apathy and depression overlap (e.g. social withdrawal or reduced initiation), pure apathy is not associated with depressive symptoms such as guilt, hopelessness or sadness [11] [12] [13] .
Many of the conceptual and theoretical frameworks for understanding apathy -across brain disorders -have focused on goal-directed behaviour. Clinically, caregivers often observe that patients require prompting to do things, but left to their own devices they do not selfinitiate behavioural activities. These types of observation have led to considerations of the underlying mechanisms that might be dysfunctional: ranging from a failure to generate options for behaviour, selecting between options depending upon valuation of their potential costs and benefits, action initiation and learning from outcomes (Figure 2 ). Analogous deconstruction of psychiatric syndromes has been put forward in the National Institute of Mental Health's Research Domain Criteria (Rod) initiative [14] . However, to date, as we shall see, very few behavioural mechanistic studies have been performed in AD.
Prevalence and impact
A recent meta-analysis covering 25 studies reported a prevalence of apathy in AD ranging from 19% to 88%, with an overall mean prevalence of 49%. The significant heterogeneity across studies was shown to depend upon the apathy scale used, disease duration, Mini Mental State Examination (MMSE) score and education level [1 ] . This might reflect difficulty to isolate apathy from symptoms of dementia, as well as symptoms of other neuropsychiatric conditions such as depression.
A number of both global and symptom-specific scales have been developed to assess the presence of neuropsychiatric symptoms, including uni-dimensional apathy measures such as the Neuropsychiatric Inventory (NPI) [15] , the Apathy Evaluation Scale (AES) [16] , the Dementia Apathy Interview and Rating Scale [17] , and the Structured Clinical Interview for Apathy [13] . Multidimensional scales measuring cognitive, behavioural, affective or social aspects of apathy might be more useful for future studies aimed at assessing the prevalence of apathy in AD. Such multi-dimensional scales include the Apathy Inventory [18], the Dimensional Apathy Scale [5], the Lille Apathy Rating Scale (LARS) [19] and the Apathy Motivation Index [4] .
Apathy appears to be associated with accelerated functional decline and increased morbidity in patients with AD. Caregiver-reported apathy, but not depression, 
